Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.

Article Details

Citation

Marchant CL, Ellis FR, Halsall PJ, Hopkins PM, Robinson RL

Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.

Muscle Nerve. 2004 Jul;30(1):114-7.

PubMed ID
15221887 [ View in PubMed
]
Abstract

Hypokalemic periodic paralysis (HypoPP) and malignant hyperthermia (MH) are autosomal-dominant genetically heterogeneous ion channelopathies. MH has been described in patients with HypoPP, suggesting a potential link between these disorders. However, a common genetic determinant has not been described. With the aim of corroborating this association, four candidate genes were screened in two independent HypoPP patients, one of whom was also diagnosed as MH-susceptible and the other as MH-normal by the in vitro contracture test (IVCT). An A>G change at nucleotide 7025 was detected in the RYR1 gene in the HypoPP/MH-susceptible patient. Detection of the same mutation in three independent MH families suggested that 7025A>G represents a novel MH-susceptibility allele and that MH and HypoPP occurred independently in the case presented. Conclusive evidence in support of the hypothesis that MH and HypoPP are allelic was therefore not obtained.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Ryanodine receptor 1P21817Details